Neratinib extends adjuvant treatment of patients with HER2-positive breast cancerAugust 26, 2018Breast Cancer
Meeting the potential of immunotherapy: new targets provide rational combinationsAugust 15, 2018Breast Cancer
Breast cancer patients don’t get the financial counseling they want from their cliniciansJuly 23, 2018Breast Cancer
FDA expands indication for ribociclib for advanced breast cancerJuly 18, 2018Breast CancerMetastatic Breast Cancer
